title: Targeted drug therapy remains a challenge.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D065731:Cytochrome P-450 CYP2C19; D017277:Drug Approval / Q000379:methods; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends*; D004345:Drug Industry / Q000379:methods / Q000639:trends*; D006801:Humans; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19